Ono Pharmaceutical Statistics
Total Valuation
OPHLY has a market cap or net worth of 5.42 billion. The enterprise value is 5.35 billion.
| Market Cap | 5.42B |
| Enterprise Value | 5.35B |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.96% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 453.34M |
Valuation Ratios
The trailing PE ratio is 11.52.
| PE Ratio | 11.52 |
| Forward PE | n/a |
| PS Ratio | 1.75 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | 9.70 |
| P/OCF Ratio | 9.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.97, with an EV/FCF ratio of 9.57.
| EV / Earnings | 11.36 |
| EV / Sales | 1.58 |
| EV / EBITDA | 6.97 |
| EV / EBIT | 8.79 |
| EV / FCF | 9.57 |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.55 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.76 |
| Interest Coverage | 34.79 |
Financial Efficiency
Return on equity (ROE) is 9.18% and return on invested capital (ROIC) is 6.19%.
| Return on Equity (ROE) | 9.18% |
| Return on Assets (ROA) | 5.56% |
| Return on Invested Capital (ROIC) | 6.19% |
| Return on Capital Employed (ROCE) | 9.15% |
| Revenue Per Employee | 804,484 |
| Profits Per Employee | 122,200 |
| Employee Count | 3,853 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.35% in the last 52 weeks. The beta is 0.17, so OPHLY's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -24.35% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 4.01 |
| Relative Strength Index (RSI) | 47.37 |
| Average Volume (20 Days) | 318,018 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OPHLY had revenue of 3.10 billion and earned 470.84 million in profits. Earnings per share was 1.00.
| Revenue | 3.10B |
| Gross Profit | 2.21B |
| Operating Income | 558.89M |
| Pretax Income | 562.77M |
| Net Income | 470.84M |
| EBITDA | 704.40M |
| EBIT | 558.89M |
| Earnings Per Share (EPS) | 1.00 |
Balance Sheet
The company has 1.09 billion in cash and 981.34 million in debt, giving a net cash position of 105.29 million.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 981.34M |
| Net Cash | 105.29M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.23B |
| Book Value Per Share | 11.05 |
| Working Capital | 1.97B |
Cash Flow
In the last 12 months, operating cash flow was 589.14 million and capital expenditures -30.28 million, giving a free cash flow of 558.87 million.
| Operating Cash Flow | 589.14M |
| Capital Expenditures | -30.28M |
| Free Cash Flow | 558.87M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 18.03% |
| Pretax Margin | 18.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 18.03% |
Dividends & Yields
This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 14.16%.
| Dividend Per Share | 0.55 |
| Dividend Yield | 14.16% |
| Dividend Growth (YoY) | 2.69% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.96% |
| Shareholder Yield | 17.12% |
| Earnings Yield | 8.68% |
| FCF Yield | 10.30% |
Stock Splits
The last stock split was on April 4, 2016. It was a forward split with a ratio of 3.
| Last Split Date | Apr 4, 2016 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |